MARKET

WST

WST

West Pharm Svcs
NYSE
351.79
+1.03
+0.29%
After Hours: 351.79 0 0.00% 16:23 12/01 EST
OPEN
350.31
PREV CLOSE
350.76
HIGH
355.17
LOW
348.96
VOLUME
271.84K
TURNOVER
0
52 WEEK HIGH
415.73
52 WEEK LOW
223.63
MARKET CAP
26.03B
P/E (TTM)
47.46
1D
5D
1M
3M
1Y
5Y
West Pharm Svcs: Current report
Press release · 3d ago
How Is The Market Feeling About West Pharmaceutical Servs?
West pharmaceutical servs's short percent of float has risen 35.93% since its last report. The company has 1.28 million shares sold short, which is 2.27% of all regular shares. Short interest is the number of shares that have been sold short but not yet covered.
Benzinga · 3d ago
Reasons to Retain West Pharmaceutical (WST) in Your Portfolio
NASDAQ · 4d ago
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Simply Wall St · 6d ago
Weekly Report: what happened at WST last week (1120-1124)?
Weekly Report · 6d ago
Best stocks for when the 10-year Treasury is falling
10-year treasury yield has tumbled since topping 5% last month. Jefferies screens for stocks with strong negative correlation to the 10-year "especially" over the last three years. Microsoft has the lowest correlation with the 10 year treasury yield in the top 10.
Seeking Alpha · 11/23 12:00
Stevanato: Guidance Reiterated And Supportive Revenue Growth
Stevanato's q3 sales missed expectations by 2%, but the company confirmed its 2023 outlook. Stevanato missed revenue by 2% in q3, but the engineering segment performed 37% yearly growth. The company's backlog is on track, and the company has a strong outlook for 2023. Tailwinds in biologics and shift toward self-administered medication trend are supportive. Stvn has a buy rating from mare evidence lab.
Seeking Alpha · 11/22 09:39
Sum Up The Parts: S&P 500 Has 12% Upside
NASDAQ · 11/20 12:24
More
About WST
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Webull offers West Pharmaceutical Services Inc. stock information, including NYSE: WST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WST stock methods without spending real money on the virtual paper trading platform.